Lineus Medical
Share
SafeBreak Vascular provides hospitals & patients protection from IV complications.
Our patented break-away device provides hospitals & patients an added layer of protection for IV access.
06/17/2026
Last week, Max Dodds represented Lineus Medical at the 2026 Cleveland Clinic Nursing Research, Innovation, and Evidence-Based Practice Conference. Congratulations to Jess Kindseth for presenting data from our Breakaway Impact Registry!
As a company built by a nurse, connecting with clinicians about driving real change in vascular access care and improving nurse workflow never gets old.
06/01/2026
We're pleased to announce that we have completed financial restructuring with KMF Investments, setting the stage for accelerated growth and a new era for SafeBreak® Vascular. This partnership fuels our mission and deepens out commitment to reduce the pains associated with IV lines for patients and nurses worldwide.
Read the full announcement to learn more:
Lineus Medical Completes Financial Restructuring with KMF Investments- Launching a New Era for SafeBreak Lineus Medical Completes Financial Restructuring with KMF Investments- Launching a New Era for SafeBreak. Lineus Medical, a leader in vascular access innovation and maker of SafeBreak® Vascular, the first breakaway device for IV lines, announced completion of a strategic recapitalization with KMF I...
05/28/2026
We're excited to share that we will be attending the Organization of Nurse Leaders (ONL) Annual Meeting in New England on June 4-5.
We're looking forward to connecting with nurse leaders and healthcare professionals about SafeBreak Vascular, sharing the latest clinical and economic data to drive important conversations shaping healthcare.
If you are attending ONL New England, stop by and say hello. We'd love to connect!
IV complications are costly for patients, nursing staff, and hospitals, but it doesn't have to be. Jess Kindseth, a Nursing & Clinical Services Practice Consultant, shares her hospital's journey from high rates of IV complications and delays in care, to a promising product trial, to standardizing SafeBreak Vascular across their entire health system.
This is the kind of impact that drives everything we do at Lineus Medical.
Watch Jess's full story below.
04/30/2026
Lineus Medical CEO, Vance Clement, is on the ground at the Minnesota Organization of Leaders in Nursing conference demoing SafeBreak Vascular and having meaningful conversations about IV care with nursing leadership.
The conference runs through today and tomorrow. If you'd like to learn more about how SafeBreak Vascular can benefit your hospital, stop by and say hi!
Evidence-based medicine isn't just a buzzword for us. It's the foundation of everything we do. From our D.I.P.P.E.R. randomized controlled trial, which demonstrated that SafeBreak Vascular reduces IV complications by 44%, to our growing Breakaway Impact Registry, we're committed to building the science behind SafeBreak.
We're now partnering with hospitals internationally to generate real-world data and advance best practices in IV care. Want to be part of it?
Contact us to learn more about joining the Breakaway Impact Registry.
Up to 46% of peripheral IVs fail before treatment is complete, and the burden of those restarts falls on nurses. SafeBreak Vascular is here to change that.
With SafeBreak on the line nurses can spend less time on restarts, and more time on focusing on their patients.
Click here to claim your Sponsored Listing.
Category
Contact the practice
Website
Address
179 N Church Avenue
Fayetteville, AR
72701